Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis

Matthew P. Giannetti,Jennifer Nicoloro-SantaBarbara,Grace Godwin,Julia Middlesworth,Andrew Espeland,Julia L. Douvas,Mariana C. Castells

DOI: https://doi.org/10.3390/diagnostics14020123

IF: 3.6

2024-01-05

Diagnostics

Abstract:Mastocytosis is a myeloproliferative neoplasm characterized by abnormal proliferation and activation of clonal mast cells typically bearing the KITD816V mutation. Symptoms manifest due to the release of bioactive mediators and the tissue infiltration by neoplastic mast cells. Mast cell activation symptoms include flushing, pruritus, urticaria, abdominal cramping, diarrhea, wheezing, neuropsychiatric symptoms, and anaphylaxis. Up to 50% of patients with mastocytosis report a history of provoked and unprovoked anaphylaxis, with Hymenoptera venom and drugs the most common culprits. NSAIDs, antibiotics, vaccines, perioperative medications, and radiocontrast media are often empirically avoided without evidence of reactions, depriving patients of needed medications and placing them at risk for unfavorable outcomes. The purpose of this review is to highlight the most common agents responsible for adverse drug reactions in patients with mastocytosis, with a review of current epidemiology, diagnosis, and management of drug hypersensitivity and Hymenoptera venom allergy.

medicine, general & internal

What problem does this paper attempt to address?

The problems that this paper attempts to solve are related to the challenges faced by mastocytosis patients in the diagnosis and management of drug and Hymenoptera venom allergies. Specifically, the paper focuses on the following aspects:

1. **Drug Allergy**: The paper explores the allergic reactions of mastocytosis patients to drugs such as non - steroidal anti - inflammatory drugs (NSAIDs), antibiotics, vaccines, peri - operative medications, and radiocontrast agents. These drugs may induce mast cell activation in patients, leading to severe allergic reactions, such as anaphylactic shock. Due to the lack of accurate epidemiological data, many doctors will recommend avoiding the use of these drugs, even without a clear history of allergy, which may also lead to patients being unable to obtain necessary treatment.

2. **Hymenoptera Venom Allergy**: Allergic reactions to Hymenoptera (such as bees, wasps, etc.) venom are more common in mastocytosis patients than in the general population. Such allergic reactions may lead to severe anaphylactic shock and even endanger lives. Therefore, how to accurately diagnose and effectively manage the allergic reactions of these patients is an important clinical issue.

3. **Diagnosis and Management Strategies**: The paper discusses in detail the current methods used for the diagnosis and management of drug allergies and Hymenoptera venom allergies, including skin tests, serum - specific IgE detection, basophil activation testing (BAT), etc. In addition, the paper also proposes preventive measures for high - risk patients, such as pre - medication (pretreatment) and step - by - step desensitization therapy (such as ultra - rapid desensitization therapy).

4. **Attention to Specific Populations**: The paper pays special attention to special groups such as children and pregnant women. Skin - type mastocytosis is more common in children, while pregnant women need to carry out appropriate drug management and allergy prevention on the premise of ensuring the safety of both mother and baby.

In general, this paper aims to provide the latest information and methods to help clinicians better diagnose and manage drug and Hymenoptera venom allergic reactions in mastocytosis patients, thereby improving the quality of life and safety of patients.